Home / News

Impartiality of Dot Pharmacy TLD Questioned

By CircleID Reporter

Catherine Saez and William New reporting in Intellectual Property Watch: “New generic top-level domain names seem set to be a constant source of discussions and dissension. The domain ‘.pharmacy’ has been awarded to a United States pharmacy association with industry backing, stirring concerns among civil society and others. But the association insists it will work in an impartial manner to ensure safety of online pharmaceutical sales… The pharmacy gTLD is expected to be launched by NABP by autumn 2014. However, according to Gabriel Levitt, vice-president of the company PharmacyChecker.com, the main funders of the NABP application are Eli Lily, Merck and Pfizer, as shown on NABP ‘coalition support’ web page.”

By CircleID Reporter —

CircleID’s internal staff reporting on news tips and developing stories. Do you have information the professional Internet community should be aware of? Contact us.

 Visit Page

Filed Under

Comments

Comment Title:

  Notify me of follow-up comments

We encourage you to post comments and engage in discussions that advance this post through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can report it using the link at the end of each comment. Views expressed in the comments do not represent those of CircleID. For more information on our comment policy, see Codes of Conduct.

CircleID Newsletter The Weekly Wrap

More and more professionals are choosing to publish critical posts on CircleID from all corners of the Internet industry. If you find it hard to keep up daily, consider subscribing to our weekly digest. We will provide you a convenient summary report once a week sent directly to your inbox. It's a quick and easy read.

Related

Topics

DNS

Sponsored byDNIB.com

IPv4 Markets

Sponsored byIPv4.Global

Threat Intelligence

Sponsored byWhoisXML API

Brand Protection

Sponsored byCSC

Domain Names

Sponsored byVerisign

New TLDs

Sponsored byRadix

Cybersecurity

Sponsored byVerisign

View All Topics